Results 221 to 230 of about 5,127,009 (325)

Dyspnea is a Conundrum in the COVID-19 Era - A Case Report

open access: gold, 2017
Nithya Rajendran   +4 more
openalex   +1 more source

Drug Resistance Predictions Based on a Directed Flag Transformer

open access: yesAdvanced Science, EarlyView.
 CAPTURE, a deep learning framework combining structural and sequence data to predict drug‐resistant Mpro mutations, revealing that PAXLOVID use may be accelerating resistance—supporting real‐time viral surveillance and therapeutic design. Abstract The evolving SARS‐CoV‐2 virus threatens global public health, particularly with potential resistance to ...
Dong Chen   +8 more
wiley   +1 more source

Perception of COVID-19 vaccines in rheumatology patients. [PDF]

open access: yesMedicine (Baltimore)
Romero-Bogado L   +16 more
europepmc   +1 more source

Health training – preparing an organism for coping with COVID-19 [PDF]

open access: gold, 2019
Piotr Gawda   +3 more
openalex   +1 more source

Machine Learning‐Enhanced Nanoparticle Design for Precision Cancer Drug Delivery

open access: yesAdvanced Science, EarlyView.
Machine Learning (ML) is revolutionizing cancer nanomedicine by optimizing nanoparticle (NP) design and drug delivery. This review summarizes ML applications across all stages of NP drug delivery, along with a discussion of ongoing challenges and future directions.
Qingquan Wang   +5 more
wiley   +1 more source

PIM1 Attenuates Innate Immunity to Foster Coronavirus Replication through Ubiquitin Ligase β‐TrCP‐Mediated IFNAR1 Degradation

open access: yesAdvanced Science, EarlyView.
Hijacking Host Kinase PIM1: A β‐Coronavirus (OC43) strategy to degrade IFNAR1 and evade antiviral immunity. Human β‐coronaviruses (OC43) exploit the proto‐oncoprotein PIM1 kinase to sabotage innate immunity. Viral RNA/proteins upregulate PIM1, which phosphorylates E3 ligase β‐TrCP1.
Qianya Wan   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy